Mandate

Vinge advises Altor in connection with its acquisition of a significant minority stake in Marshall Group AB (publ)

Vinge advises the Altor Funds (“Altor”) in connection with its acquisition of a significant minority stake in Marshall Group AB (publ) (“Marshall”) from Varenne AB, Varenne Invest I AB, Zenith Venture Capital I AB, Zenith Venture Capital III AB as well as a large number of smaller investors.

Marshall is an audio-, tech- and design powerhouse, active in more than 90 markets, with approximately SEK four billion of revenues and employs approximately 800 people across eight locations globally.

Vinge’s team consisted mainly of Christina Kokko, Johanna Wiberg and Viktor Lennartsson (M&A), David Olander (Competition), Victor Ericsson and Emelie Svanberg (Tax).

Related

Vinge has advised Vimian Group AB in connection with its uplisting to Nasdaq Stockholm

Vinge has advised Vimian Group AB (publ) in connection with its list change from Nasdaq First North Growth Market to Nasdaq Stockholm’s main market, Large cap. The prospectus was published on 21 March 2025 and the trading on Nasdaq Stockholm commenced on 28 March 2025.
March 28, 2025

Vinge advises Tribune Therapeutics in conjunction with financing round

Vinge advises Tribune Therapeutics, a Swedish biotechnology company focused on developing therapies for fibrotic diseases, in raising 23 MEUR. The financing round includes the previous investors HealthCap, Novo Holding and Innovestor, in addition to the new investors LifeArc Ventures, Industrifonden and Investinor.
March 26, 2025

Vinge advises Dignitana on the public offer from Paxman

Paxman AB (publ) has announced a public offer to the shareholders of Dignitana AB. The total value of the offer is approximately SEK 153 million.
March 24, 2025